Ho Gyun Park1, Oh Seok Ko1, Young Gon Kim1, Jong Kwan Park2. 1. Department of Urology, Chonbuk National University Medical School, Jeonju, Korea. 2. Department of Urology, Chonbuk National University Medical School, Jeonju, Korea. ; Institute for Clinical Medicine, Chonbuk National University Medical School, Jeonju, Korea. ; Biomedical Research Institute, Chonbuk National University Medical School, Jeonju, Korea. ; Clinical Trial Center of Medical Devices, Chonbuk National University Medical School, Jeonju, Korea.
Abstract
PURPOSE: Prostate cancer is rare in men younger than 50 years. Digital rectal examination (DRE) and measurement of prostate-specific antigen (PSA) concentrations are standard screening methods for detecting prostate cancer. We retrospectively investigated the risks and benefits of repeated transrectal ultrasonography-guided prostate needle biopsies in relation to the follow-up status of men younger than 50 years with a consistently high PSA concentration (>3.0 ng/mL). MATERIALS AND METHODS: During the period from January 2000 through February 2013, we reviewed patient's ages, dates of procedures, DRE results, frequencies of biopsies, results of the biopsies, periods of follow-up, PSA concentrations, and prostate volumes in Chonbuk National University Hospital records. We conducted telephone interviews in patients who did not undergo regular follow-up. RESULTS: The mean age of the patients was 44.7 years, and the mean PSA concentration was 8.59 ng/mL (range, 3.04-131 ng/mL) before biopsy. The PSA concentration was significantly different (p<0.001) between the patients with prostate cancer and those with benign prostatic hyperplasia (BPH). Nineteen patients underwent repeated prostate biopsy; however, in only one patient did the pathologic findings indicate a change from BPH to prostate cancer. We identified several complications after transrectal biopsy through an evaluation of follow-up data. CONCLUSIONS: All patients with benign prostatic disease based on their first biopsy were shown to have benign disease based on all repeated biopsies (15.83%), except for one patient; however, several complications were noted after biopsy. Therefore, the risks and benefits of repeated biopsy in young patients should be considered because of the low rate of change from benign to malignant disease despite continuously high PSA concentrations (>3.0 ng/mL).
PURPOSE:Prostate cancer is rare in men younger than 50 years. Digital rectal examination (DRE) and measurement of prostate-specific antigen (PSA) concentrations are standard screening methods for detecting prostate cancer. We retrospectively investigated the risks and benefits of repeated transrectal ultrasonography-guided prostate needle biopsies in relation to the follow-up status of men younger than 50 years with a consistently high PSA concentration (>3.0 ng/mL). MATERIALS AND METHODS: During the period from January 2000 through February 2013, we reviewed patient's ages, dates of procedures, DRE results, frequencies of biopsies, results of the biopsies, periods of follow-up, PSA concentrations, and prostate volumes in Chonbuk National University Hospital records. We conducted telephone interviews in patients who did not undergo regular follow-up. RESULTS: The mean age of the patients was 44.7 years, and the mean PSA concentration was 8.59 ng/mL (range, 3.04-131 ng/mL) before biopsy. The PSA concentration was significantly different (p<0.001) between the patients with prostate cancer and those with benign prostatic hyperplasia (BPH). Nineteen patients underwent repeated prostate biopsy; however, in only one patient did the pathologic findings indicate a change from BPH to prostate cancer. We identified several complications after transrectal biopsy through an evaluation of follow-up data. CONCLUSIONS: All patients with benign prostatic disease based on their first biopsy were shown to have benign disease based on all repeated biopsies (15.83%), except for one patient; however, several complications were noted after biopsy. Therefore, the risks and benefits of repeated biopsy in young patients should be considered because of the low rate of change from benign to malignant disease despite continuously high PSA concentrations (>3.0 ng/mL).
Entities:
Keywords:
Biopsy; Follow-up studies; Prostate; Prostate-specific antigen; Young adult
Authors: Leon Sun; Judd W Moul; James M Hotaling; Edward Rampersaud; Phillipp Dahm; Cary Robertson; Nicholas Fitzsimons; David Albala; Thomas J Polascik Journal: BJU Int Date: 2007-01-19 Impact factor: 5.588
Authors: Ganesh S Palapattu; Siobhan Sutcliffe; Patrick J Bastian; Elizabeth A Platz; Angelo M De Marzo; William B Isaacs; William G Nelson Journal: Carcinogenesis Date: 2004-10-21 Impact factor: 4.944
Authors: Ja Hyeon Ku; Jae Ouk Ahn; Chang Ho Lee; Nam Kyu Lee; Young Ho Park; Seok Soo Byun; Cheol Kwak; Sang Eun Lee Journal: Urology Date: 2002-09 Impact factor: 2.649
Authors: Young Jung Kim; Sun-Ouck Kim; Kwang Ho Ryu; In Sang Hwang; Eu Chang Hwang; Kyung Jin Oh; Seung Il Jung; Taek Won Kang; Dong Deuk Kwon; Kwangsung Park; Soo Bang Ryu Journal: Korean J Urol Date: 2011-07-24